Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 15297968)

1.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z.

Hum Pathol. 2004 Aug;35(8):1008-13.

PMID:
15297968
2.

Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.

Jiang Z, Woda BA.

Adv Anat Pathol. 2004 Nov;11(6):316-21. Review.

PMID:
15505533
3.

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Jiang Z, Woda BA, Wu CL, Yang XJ.

Am J Clin Pathol. 2004 Aug;122(2):275-89. Review.

5.

In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.

Clouston D, Bolton D.

BJU Int. 2012 Apr;109 Suppl 3:22-6. doi: 10.1111/j.1464-410X.2012.11040.x. Review.

PMID:
22458488
6.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
7.

[Value of new prostate cancer markers: alpha methylacyl CoA racemase (P504S) and p63].

Molinié V, Hervé JM, Lugagne PM, Yonneau L, Ellard S, Lebret T, Botto H.

Prog Urol. 2005 Sep;15(4):611-5. Review. French.

PMID:
16459672
8.
10.

Human prostate cancer precursors and pathobiology.

De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG.

Urology. 2003 Nov;62(5 Suppl 1):55-62. Review.

PMID:
14607218
11.

Intermediate biomarkers for chemoprevention of prostate cancer.

van der Kwast TH.

IARC Sci Publ. 2001;154:199-205. Review.

PMID:
11220659
12.

Diagnostic limits in precursor lesions of prostatic cancer.

Algaba F, Trias I.

Eur Urol. 1996;30(2):212-21. Review.

PMID:
8875203
13.

Molecular biology of prostatic intraepithelial neoplasia.

Bostwick DG, Pacelli A, Lopez-Beltran A.

Prostate. 1996 Aug;29(2):117-34. Review.

PMID:
8700801
14.

Precursor lesions to prostatic adenocarcinoma.

Epstein JI.

Virchows Arch. 2009 Jan;454(1):1-16. doi: 10.1007/s00428-008-0707-5. Epub 2008 Dec 2. Review.

PMID:
19048290
15.

High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction.

Steiner MS.

World J Urol. 2003 May;21(1):15-20. Epub 2003 Feb 21. Review.

PMID:
12756489
16.

Cellular and molecular pathology of prostate cancer precursors.

Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R, Sakr WA.

Scand J Urol Nephrol Suppl. 2000;(205):19-43. Review.

PMID:
11144897
17.

High grade prostatic intraepithelial neoplasia is a disease.

Steiner MS.

Curr Urol Rep. 2001 Jun;2(3):195-8. Review.

PMID:
12084264
18.

Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Bostwick DG, Montironi R, Sesterhenn IA.

Scand J Urol Nephrol Suppl. 2000;(205):3-10. Review.

PMID:
11144902
19.

High-grade prostatic intraepithelial neoplasia.

Bostwick DG, Qian J.

Mod Pathol. 2004 Mar;17(3):360-79. Review.

20.

α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S.

Lloyd MD, Yevglevskis M, Lee GL, Wood PJ, Threadgill MD, Woodman TJ.

Prog Lipid Res. 2013 Apr;52(2):220-30. doi: 10.1016/j.plipres.2013.01.001. Epub 2013 Jan 29. Review.

PMID:
23376124
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk